Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0b013e3182291c3d | DOI Listing |
Diagnostics (Basel)
October 2024
Department of Nuclear Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON M4N 3M5, Canada.
Cureus
September 2024
Nuclear Medicine and Positron Emission Tomography/Computed Tomography (PET/CT), King Hussein Cancer Center (KHCC), Amman, JOR.
World J Nucl Med
September 2024
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital, Mumbai, Maharashtra, India.
We herein present a patient initially suspected of multiple lytic skeletal metastasis of unknown primary on anatomical imaging. Metabolic imaging by [18F]-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) detected focal [18F]FDG uptake in the right thyroid nodule, mild [18F]FDG uptake in soft tissue lesion in the left inferior parathyroid region, and multiple nonavid osteolytic skeletal lesions. Fine-needle aspiration cytology of the right thyroid nodule showed papillary thyroid carcinoma (PTC).
View Article and Find Full Text PDFArch Clin Cases
December 2023
Instituto Nacional de Cancerologia, Bogota, Colombia.
Prostate cancer is the second most common malignancy in men worldwide, with a good prognosis when is detected and treated in early stages, but, when it presents progression to castration-resistant metastatic prostate cancer, most of the cases will have bone metastasis, decreasing the quality of life and life expectancy. For the evaluation of the disease in the routinary clinical practice, Ga-PSMA PET/CT, among others is a valuable tool for the evaluation of the disease extension. Ga-PSMA PET/CT detects the presence of PSMA receptor in the tumoral tissue, but also has physiologic uptake in certain organs, such as liver, spleen, intestine, kidneys, lacrimal and salivary glands.
View Article and Find Full Text PDFRadiol Case Rep
December 2023
Department of Radiology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
This report presents the imaging findings in a patient with advanced prostate cancer and bone metastases. A superscan pattern on the initial whole-body bone scan suggested extensive disease. The patient responded well to definitive treatment, exhibiting clinical improvement based on decreased PSA levels and CT findings in 6-month follow-up.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!